+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SUNREST

Sunrest Lifescience Share Price

 

 

Sunrest Lifescience live price: ₹35.6. It opened at ₹36 vs previous close ₹34; intraday high/low: ₹36/₹36. The 50 & 200 DMA stand at ₹36.22/₹42.33.

Sunrest Lifescience Performance

  • Today's Low
  • ₹36
  • Today's High
  • ₹36
  • 52 Week Low
  • ₹26
  • 52 Week High
  • ₹54
  • Open Price₹36
  • Previous Close₹34
  • Volume3,200
  • 50 DMA₹36.22
  • 100 DMA₹38.00
  • 200 DMA₹42.33

Sunrest Lifescience Chart

Investment Returns

  • Over 1 Month + 4.71%
  • Over 3 Month -5.07%
  • Over 6 Month -11.35%
  • Over 1 Year -23.28%

Smart Investing Starts Here Start SIP with Sunrest Lifescience for Steady Growth!

Invest Now

Sunrest Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 3.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 31
  • P/B Ratio
  • 1.2
  • Average True Range
  • 1.52
  • EPS
  • 4.8
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.86
  • RSI
  • 50.55
  • MFI
  • 47.49

Latest Stock News Updates

Sunrest Lifescience IPO: GMP, subscription status, issue details, top 10 things you need to know

SME IPO- Sunrest Lifescience opened for subscription on November 7 and closes on November 9. It is a fixed price issue of 10.85 crore. The issue is entirely a fresh issue of 12.91 lakh shares. Sunrest Lifescience IPO price is 84 per share. The issue subscribed 3 times today sees GMP at Rs22.

Sunrest Lifescience Financials

Sunrest Lifescience Technicals

EMA & SMA

Current Price
₹35.60
+ 1.6 (4.71%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹35.00
  • 50 Day
  • ₹36.20
  • 100 Day
  • ₹38.00
  • 200 Day
  • ₹42.30

Resistance and Support

35.6 Pivot Speed
  • R3 35.60
  • R2 35.60
  • R1 35.60
  • S1 35.60
  • S2 35.60
  • S3 35.60

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sunrest Lifescience Ltd has an operating revenue of Rs. 104.25 Cr. on a trailing 12-month basis. An annual revenue growth of 119% is outstanding, Pre-tax margin of 14% is healthy, ROE of 39% is exceptional. The company has a debt to equity of 59%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 11 which is a POOR score indicating inconsistency in earnings, a RS Rating of 28 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 36 indicates it belongs to a strong industry group of Medical-Supplies and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sunrest Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-02 Fund Raising & Others To consider other business matters. issue of equity shares of Rs. 10/- in the ratio of 1:1 @ premium of Rs. 25/-.
2026-06-26 Fund Raising & Others To consider other business matters. issue of equity shares of Rs. 10/- in the ratio of 1:1 @ premium of Rs. 25/-.
2026-05-29 Audited Results
2026-03-16 Fund Raising & Others (Revised) To consider other business matters. issue of equity shares of Rs. 10/- in the ratio of 1:1 @ premium of Rs. 25/-.
2026-02-19 Fund Raising & Others To consider other business matters. issue of equity shares of Rs. 10/- in the ratio of 1:1 @ premium of Rs. 25/-.

Sunrest Lifescience Shareholding Pattern

53.5%
36.36%
10.14%

Sunrest Lifescience FAQs

Sunrest Lifescience share price is ₹35 As on 07 July, 2026 | 13:42

The Market Cap of Sunrest Lifescience is ₹30.6 Cr As on 07 July, 2026 | 13:42

The P/E ratio of Sunrest Lifescience is 3.8 As on 07 July, 2026 | 13:42

The PB ratio of Sunrest Lifescience is 1.2 As on 07 July, 2026 | 13:42

Open FREE Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23